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Abstract
Background It has been shown that transcutaneous electri-
cal neurostimulation (TENS) reduces sympathetic tone.
Spinal cord stimulation (SCS) has proven qualities to
improve coronary, peripheral, and cerebral blood circula-
tion. Therefore, we postulate that TENS and SCS affect the
autonomic nervous system in analogous ways. In this line
of thought, cervical application of TENS might be a useful
and simple adjunct in the treatment of cerebrovascular
disease by improving cerebral blood flow. Experiments
were performed in order to assess whether cervical TENS is
safe and whether an effect on cerebral blood flow velocity
(CBFV) can be shown in healthy subjects.
Method A controlled, non-randomized, phase 1 study was
performed with 20 healthy volunteers. Cervical TENS was
applied in several frequencies, with and without hyperven-
tilation. Continuous registration of blood pressure, pulse,
CBFV (estimated by transcranial Doppler sonography) and
end-tidal carbon dioxide concentration was performed.
Findings Cervical TENS was well-tolerated by all subjects.
Despite small effects on heart rate (HR) and mean arterial
blood pressure (MAP), a significant effect on middle
cerebral artery (MCA) blood flow velocity was not
demonstrated. No effect of age, gender, current or session
order on MCA, HR, or MAP was found. TENS did not
influence the effect of hyperventilation.
Conclusions In these experiments, application of cervical
TENS is proven to be a safe procedure. However, no effects
on cerebral blood flow velocity could be detected, perhaps
due to the intact cerebral autoregulation in the healthy
volunteers.
Keywords Cerebrovascular circulation.Transcutaneous
electric neurostimulation.Intracranial vasospasm.
Sympathetic nervous system
Introduction
Spinal cord stimulation (SCS) is widely used in the
treatment of pain. Although several mechanisms have been
proposed, its exact mechanism of action remains unclear
[13]. At least part of the effects of SCS is mediated by the
autonomic nervous system, as shown by the fact that
sympathetically mediated pain (e.g., visceral pain and
complex regional pain syndromes) responds better than
nociceptive pain to SCS treatment [13]. In addition, it has
been demonstrated that SCS has autonomic (side)effects,
such as increasing peripheral blood flow in Raynaud's
phenomenon, peripheral ischemic pain, coronary disease,
and complex regional pain syndromes [4, 11, 13]. Since the
sympathetic fibers are located ventrally in the spinal cord
and SCS electrodes are placed dorsally, these ventral fibers
are not located within the electrical field. Therefore, these
autonomic effect must be indirect, e.g., via antidromic
pathways [13].
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been used since 1974 to test the tolerance for stimuli in the
work-up for SCS [1]. Some of the effects seen in SCS can
be produced by TENS as well. Effects on peripheral blood
flow have been shown, as well as increased coronary
perfusion [12]. An experiment on autonomic cardiovascular
reflexes demonstrated a decreased sympathetic response
when using TENS [17]. Since the sympathetic effects as
shown by SCS must be indirect effects of the electrical
stimulation, we postulate that TENS produces these effects
in the same way.
In several studies, an increase of cerebral blood flow
(CBF) has been described as a result of cervical SCS [2, 3,
9, 10]. The effects of SCS on CBF are most likely mediated
through the sympathetic nervous system, since cerebral
vasculature is highly sympathetically innervated and the
vascular diameter is related to sympathetic tone [18]. Patel
showed that this effect is mediated via a central pathway
[15]. This pathway involves brainstem vasomotor centers
that connect with the cerebral microvasculature through
intrinsic nerve pathways. In experiments on rats, he showed
that surgical sympathectomy failed to influence the CBF
response caused by cervical SCS, while transsection of the
spinal cord at the cervicomedullary junction completely
abolished all increases in CBF. Taking into account the
proven effect of TENS on peripheral blood flow and its
(indirect) effect on sympathetic tone, TENS should be able
to alter CBF, an analog to SCS. As such, TENS could be a
useful non-invasive adjunct in the treatment of cerebrovas-
cular disease (CVD).
TENS either has a direct effect on vascular diameter or
has an effect on the sympathetic tone. If the latter is true,
then, in resting conditions, there should be no effect on
CBF. Therefore, in order to find out whether the sympa-
thetic tone is reduced by TENS, the effects of TENS on
CBF in hyperventilating subjects is of interest. Given that
cerebral blood flow in response to hyperventilation might
partially be sympathetically mediated [7, 8], this response
should be reduced by TENS.
As cervical TENS is a novel potential therapeutic
application in the treatment of CVD, this paper describes
the experiments that were performed to assess the effects of
TENS on CBF in healthy subjects and to register its
potential side effects.
Materials and methods
Study design
The study was designed as a controlled (subjects were their
own controls), non-randomized phase 1 experiment.
Healthy volunteers were recruited from the general public
by advertisement in the local newspapers. Cerebral blood
flow velocity (CBFV) can be seen as a representation of
CBF when the vascular cross-sectional area (CSA) remains
constant (CBFV=CBF/CSA). Cerebral blood flow velocity
was measured by transcranial Doppler (TCD) of the medial
cerebral artery (MCA). The trial has been authorized by the
local Research Ethical Board and the Dutch Central
Commission of Human Research.
Sample size calculation
The literature reports inter-individual standard deviation of
flow velocities as about 15% [21] and the intra-individual
standard deviation as 8% [14]. Sample size calculation is
based on the requirement that a difference in flow velocities
of 20 cm/s (ca 20%) between frequencies 2 and 120 Hz
should be detected with a probability (power) of 90% when
testing at a significance level of 5% two-sided. This results
in a sample size of 20.
Treatment of subjects
The subjects were treated with conventional TENS,
providing a continuous flow of symmetrical rectangular
biphasic pulses (Schwa Medico, Pierenkemper GMBH;
Wetzlarestr. 41-43, D-35630, Ehringhausen, Germany).
Stimulation was performed at 90% of the highest tolerated
current, with a pulse-width of 200 ms. Stimulation
frequencies were 2, 20, 50, 100, and 120 Hz. In this way,
the entire range of possible TENS frequencies and the most
used frequencies in current TENS treatments were captured.
Subjects were supine during the entire experiment. The
TENS electrodes were applied cervical at the height of the
mandible on both sides of the nuchal ligament (dermatome
C2-C3). Doppler probes were applied to the skull for
continuous registration of flow velocity in the MCA (left
and right). Continuous registration of pulse and blood
pressure was recorded by plethysmography.
For the first experiment (Fig. 1), five blocks of measure-
ments took place for each TENS frequency, 5 min of
registration without TENS, and followed by 5 min with
TENS (so each TENS frequency had its own control-
baseline). The order of frequencies was randomized (using
the QuickCalcs online calculator, GraphPad Software, Inc.)
in order to correct for possible alteration in time of the
sympathetic tone during the experiment.
The second experiment (Fig. 2) was designed to examine
whether TENS influences the normal cerebral regulation
that physiologically occurs in reaction to hyperventilation.
In the same way as the first experiment, blocks of
measurements were recorded, now at a fixed frequency of
100 Hz. For practical purposes, only one frequency was
used for this experiment. The frequency of 100 Hz was
1368 M. ter Laan et al.chosen because it has been used in previous TENS
experiments to alter blood flow in coronary arteries [5].
During this part of the experiment, end-tidal partial carbon
dioxide concentration (ETCO2) was measured in the
exhaled air as a measure of hyperventilation. Hyperventi-
lation was defined as a decrease of ETCO2 to 2%.
Measurements were performed following the scheme below
(in half of the subjects the order was reversed, i.e., first
TENS with hyperventilation):
– Three minutes registration with hyperventilation (1 min
to achieve an ETCO2 of 2%, 2 min measurement)
– Ten minutes registration without TENS/hyperventila-
tion
– Three minutes registration with TENS and hyperventi-
lation (1 min to achieve an ETCO2 of 2%, 2 min
measuring)
– Ten minutes registration without TENS or until
baseline variables were approached
Data processing
Data was collected using a continuous TCD monitor (DIGI-
LITEtm, Raanana, Israel), a plethysmograph for assessing
blood pressure and pulse (Finometer-Pro, Finapress Medical
Systems, Amsterdam, The Netherlands), an electrocardio-
graph (Finometer-Pro, Finapress Medical Systems, Amster-
dam,TheNetherlands),andacapnograph(CapnomacUltima,
GEHealthcare,ChalfontStGiles,UK).Allanalogoutputwas
routed to a computer via a digitizer. The data were
continuously registered using Neuromon (incorporating Lab-
view 7.1, National Instruments) software. Before statistical
analysis, all artifacts were deleted from the data streams (e.g.,
reduced Doppler signal due to transducer dislodgement). In
order to clean the data from noise, filtering was performed
using in-house written routines in the Matlab environment
(The Math Works, Inc., Natwick, MA, USA, Matlab 6.5).
Bandwidths for the data were defined (50–150 bpm for HR,
5–100 cm/s for MCA, 60–180 mmHg for ABP, and 2–6% for
CO2 in resting phase), and top and bottom 10% of data were
deleted, replacing those by linear interpolation. Next, 3-min
data streams were taken from each measurement, in each case
as t r e a mf r o m−4t o−1 min before the start of TENS and a
stream from +1 to +4 min after the start of TENS. From the
hyperventilation data, a stream was taken from −2.5 to
−0.5 min from the start of HV and another 2-min stream as
soon as ETCO2 had stabilized around 2–2.5% (app. 15–
20 mmHg). Average values of all streams were calculated and
used for statistical analysis.
Statistical analysis
The purpose of the analysis was to find out (1) the effect of
different TENS frequencies on cerebral blood flow and (2)
whether the TENS frequency of 100 Hz modifies the effect
of hyperventilation on cerebral blood flow. The data from
the first experiment were used to address the first question
and the data from the second experiment to address the
second question. For each TENS frequency, we subtracted
the measurement at the preceding non-TENS session from
the measurement with TENS and used these “baseline-
corrected” differences as basic outcomes in the analysis. We
used all observations from the MCA side which had the
highest blood flow velocity at baseline as measured by
TCD. For both questions, the analysis consisted of fitting
mixed effects regression models to the data [16]. For
question 1, we have used the TENS frequency (at five
levels), the order of observations, age, and gender of the
participants as fixed effect explanatory variables. For
question 2, the fixed effects were TENS frequency (0 or
100), ETCO2, age, and gender. Statistical tests were carried
out at 5% level of significance. We used the statistical
package R for computations (version 2.8.1; library nlme).
Results
A group of 11 females and nine males, all healthy subjects,
completed the experiment, in age ranging from 25 to
65 years (median 46.5 years). Two more volunteers
participated, but their measurements failed. In one individ-
ual, the temporal bony windows were insufficient to obtain
Fig. 2 Set-up of experiment 2: two blocks of baseline measurements,
followed by a measurement with hyperventilation either with or
without TENS. Order of measurements was reversed in half of
subjects
Fig. 1 Set-up of experiment 1: five blocks of baseline measurements
followed by 5-min measurement with TENS in randomized frequen-
cies 1 to 5
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of noise was perceived on all signals; therefore, the
experiment was aborted.
All volunteers tolerated TENS well, though the highest
tolerated current did vary from 10 to 35 mA. The only
adverse events reported by the volunteers were pressure
from the cap used to position the TCD probes and tingling
sensations or dizziness as a result of the hyperventilation.
All volunteers reached the predefined threshold of an
ETCO2 of 2% during hyperventilation.
Figure 3a shows box plots with values of MCA blood
flow velocities, blood pressures (MAP), and pulse (HR)
without TENS and per TENS frequency for the first
experiment. Box plots in Fig. 3b show differences between
MCA blood flow velocities, MAPs and HR, and their
coupled baseline values. The mean differences and the
corresponding confidence intervals for MCA, HR, and
MAP are shown in Table 1. The effect of TENS on MCA
was on average 0.78 cm/s (95% CI; 0.06 to 1.50), the
effects at different TENS frequencies were not statistically
significantly different (P=0.80). For HR and MAP, too, the
effects of different TENS frequencies did not differ (P=
0.06 and P=0.14, respectively). Compared with the
baseline, the HR was significantly lower at 120 Hz, and
the MAP was significantly higher at 2, 50, and 100 Hz.
However, the effects are so small, that they cannot be
judged clinically relevant. No effect of age, gender, or
session order on MCA, HR, or MAP was found.
Fig. 3 Box plots of mean values
of cerebral blood flow velocities
in MCA (centimeters per sec-
ond), heart rate (HR; beats per
minute), and mean arterial pres-
sure (MAP; millimeters of Hg)
at the different TENS frequen-
cies (a 0=baseline). The plots in
b show the differences of the
mean values when compared
with baseline
Table 1 Differences of MCA blood flow velocities (MCA), heart rates (HR), and mean arterial blood pressures (MAP) for each TENS frequency
compared with their coupled baseline values
MCA HR MAP
Frequency Effect 95% CI Effect 95% CI Effect 95% CI
2 Hz 1.019 (−0.277, 2.315) −0.233 (−1.410, 0.944) 2.133
a (0.720, 3.547)
20 Hz 0.399 (−0.897, 1.695) −0.453 (−1.750, 0.844) 0.876 (−0.570, 2.322)
50 Hz 1.247 (−0.049, 2.543) −0.116 (−1.369, 1.137) 2.565
a (1.152, 3.979)
100 Hz 0.874 (−0.423, 2.170) 0.713 (−0.500, 1.927) 2.180
a (0.766, 3.593)
120 Hz 0.347 (−0.931, 1.661) −1.844
a (−3.057, −0.631) 0.668 (−0.778, 2.115)
Overall 0.781 (0.060, 1.501) −0.390 (−0.971,0.191) 1.708 (0.825,2.591)
aSignificant effect
1370 M. ter Laan et al.Figure 4a, b show box plots of values of MCA blood
flow, blood pressure, and pulse for experiment 2: with and
without TENS, and with and without hyperventilation. No
significant effect of TENS on MCA, HR, or MAP on the
effect of hyperventilation was detected (P values 0.43, 0.58,
0.31, respectively). ETC02 (difference between the measure-
ments with and without hyperventilation) was found to be
positively related to MCA and negatively to HR (P<0.001).
Because the highest tolerated current varied between
volunteers from 10 to 35 mA, we have also included the
current in the fixed-effects model. No statistically signifi-
cant effects of current could be found.
Discussion
We have studied whether TENS can influence the cerebral
blood flow in healthy subjects. We postulated that TENS
might influence cerebral blood flow via sympathetic path-
ways as observed in experiments with SCS [2, 3, 6, 9–11,
13, 15]. Also, TENS has been shown to increase locore-
gional blood flow and sympathetic tone [12, 17].
The purpose of this study was twofold: (1) to find out if
the use of cervically applied TENS is safe and (2) to find
out the effect on CBF in healthy subjects.
We suggested TENS might either (indirectly) create a
sympathetic response that influences CBF or TENS might
alter the sympathetic tone. To test the first way of action,
we performed experiment 1 in which CBF was measured
during stimulation with several TENS frequencies in resting
healthy subjects. If only sympathetic tone is influenced by
TENS, subjects in rest will not show an effect, but subjects
that have to apply their autonomous nervous system might.
Because the cerebral response to carbon dioxide changes
might be partially sympathetically mediated [7, 8], we have
also tested whether TENS influences the response to
hyperventilation.
Because sympathetic tone can easily change during an
experiment (an individual can become either more or less
comfortable during the experiment), we have applied
several measures to compensate for this effect. Firstly, we
have randomized the order of applied TENS frequencies;
secondly we have provided each frequency with its own
control-baseline-measurement, and thirdly, the order of
TENS with/without hyperventilation varied.
TENS was tolerated very well by all subjects. No
adverse events were found. Also, systemic blood pressure
and heart rate were not affected by TENS in a clinically
relevant manner.
As for the effect of TENS on CBF, no statistically
significant effects were found for the individual TENS
frequencies, neither at rest nor in the hyperventilation
experiment. Overall, there was a small increase of MCA
blood flow velocity (0.78 cm/s) when TENS is compared
with rest. The fall in MCA blood flow velocity as a result of
hyperventilation was a little less prominent when TENS
was applied, but this did not reach statistical significance.
Several explanations can be advanced as to why no
effect was found. Firstly, of course, there might be no effect
at all. Secondly, TENS might not be powerful enough
Fig. 4 Box plots of mean values
of MCA blood flow velocities
(centimeters per second), heart
rate (HR; beats per minute), and
mean arterial pressure (MAP;
millimeters of Hg), for baseline
(c1 and c2), hyperventilation
(HV), and hyperventilation
combined with TENS (HV+; a).
Differences of the mean values
of TENS with (TENS+) and
without (TENS−) hyperventila-
tion, compared with their base-
lines are shown in (b)
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current. However, we did not find a difference between
volunteers that tolerated higher and volunteers that tolerated
lower currents. Thirdly, we have only used one frequency
in the hyperventilation experiment; possibly, other frequen-
cies give different results. Fourthly, one might have to
apply TENS for a longer period, although we do not think
this is plausible, given the results of other TENS studies.
Finally, regulatory mechanisms of CBF are complex. CBF
depends on several parameters including MAP, ICP, CO2,
O2, and other (auto)regulatory mechanisms. The role of the
sympathetic nervous system on these parameters remains
unclear. Sympathetic tone does regulate MAP by means of
peripheral vasoconstriction in organ beds, but there is
ongoing debate about the sympathetic effects on cerebral
vasculature [19, 20]. Also, the effects of CO2 might be far
stronger than the sympathetic effects; possibly, sympathetic
tone only has a modulating effect [8]. Moreover, the study
was performed in healthy subjects with a powerful, intact
autoregulation. This might have masked the effects of
TENS on sympathetic tone.
The power analysis was aimed at finding a clinically
significant effect; thus, with our experiments, we can only
conclude that there seems to be no such effect in a healthy
population. This does not yet prove that TENS does not
influence the sympathetic nervous system and CBF,
especially because we did notice a tendency towards less
decreased blood flow velocities in reaction to hyperventi-
lation when TENS was applied.
Possibly, an effect of TENS is appreciated in patients with
disturbed autoregulation, e.g., patients with cerebral ischemia
or following subarachnoid hemorrhage (with locally dis-
turbed blood–brain barrier). Since cervical TENS did not
have a clinically relevant effect on systemic blood pressure
and heart rate, TENS can be safely applied to those patients.
We think it is important to further investigate the effect of
TENS on CBF in the presence of a disturbed autoregulation,
especially since the influence of sympathetic tone is possibly
much more significant in these pathological situations.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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Comment
This study seeks to evaluate the efficacy and application of
electromagnetic fields to modulate and treat cerebrovascular disease.
The device of choice was the transcutaneous electrical neurostimulator
(TENS); the end-point followed was cerebral blood flow in the middle
cerebral artery, as measured by transcranial doppler ultrasonography.
Within the 20 patients examined, no significant difference in outcomes
was noted.
While simple, this paper provides a vital critique of popular
mode of treatment. The use of electromagnetic and other non-
invasive techniques to modify physiology has been proposed for
over a century. More and more we see variations on this in
products from industry designed to treat diseases without pills or
surgery. The pursuit of non-invasive therapies is wonderful, but this
article reminds us of the need to be rational and critical in our
evaluation of novel therapies.
Markus Bookland, MD
Christopher M. Loftus MD
Philadelphia, USA
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